What we do

Interstitial Lung Disease (ILD)

Data shows frequent home spirometry enables more sensitive prediction of disease prognosis than periodic hospital based measurement¹

Patient-centred care

Data-enabled treatment decisions are made according to patient need, not as determined by the appointment review schedule.

Supports earlier clinical identification of disease progression

Data shows frequent home spirometry enables more sensitive prediction of disease prognosis than periodic hospital based measurement¹

Rapid identification of exacerbations

Automated alerting of lung function decline for earlier patient management.

Main features

Automated alerting

For rapid identification of exacerbations and other complications.

More than home spirometry

Remote monitoring of oximetry, BP, weight, temperature, activity, dyspnoea, and patient-reported outcomes

Integrated spirometry quality validation

For confident clinical decision-making and definitive research findings.

High patient engagement

91% adherence to daily home monitoring.

High correlation with clinic spirometry

Across multiple fibrotic ILD subtypes.

Clinical evidence

Filter

ILD

ILD: Researchers at Beaumont Hospital are examining the use of remote monitoring via patientMpower for the early identification of progression in connective tissue ILD

ILD: Multi-centre study confirms feasibility and clinical utility of remote monitoring using the patientMpower platform as part of an ILD clinical service

Daily home spirometry performed via the patientMpower platform is feasible, reliable and is highly correlated with hospital spirometry

User Experience of patientMpower Electronic Health Journal for Pulmonary Fibrosis in Volunteers Recruited Via the PF Warriors Support Group

Virtual Care for Cystic Fibrosis: Experience from Galway University Hospital

“It helps us identify if we need to see that patient in person. Patients know that the information has gone directly to their nurse or doctor – so they can have a better conversation about how they are feeling“

Prof. Killian Hurley,

Respiratory Consultant, Beaumont Hospital, Dublin

Clinical and research partners in ILD

Patient engagement partners

Platform functionality

Integrated devices

Spirometry, pulse oximetry, blood pressure, body weight, temperature, activity tracking and more.

Patient reported outcomes

Inbuilt specialised ePRO including KBILD, IPF-PROM, and L-PF.

Platform features

Automated alerting, spirometry quality validation, 1MSTS, tailored educational content, and medication reminders.